CCR2 inhibitors (DuPont)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCCR2 inhibitors (DuPont)
Drug Alias NameSA-225
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsInflammationHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Pharma Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Pharma Company
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A